Clinical Trials

Lazaro Barajas’ cancer had developed resistance to standard chemotherapy and immunotherapy

Lazaro Barajas will be honored as a Laker For A Day, for his courage and determination

‘We have a very large clinical trial profile which allows us to have access to novel therapies and new treatment strategies,’ says Dr. Ritu Salani

VALOR trial aims to discover the optimal treatment for stage 1 lung cancer

A UCLA HemOnc Fellow is determined to reduce cancer disparities

The first participant in the trial not only decreased his daily insulin use by 91%, but for the first time in his life, his body is producing insulin in response to blood sugar fluctuation

What makes this parasomnia so frightening?

Groundbreaking science and cross-specialty collaboration enable transplant recipients to thrive without immunosuppressive drugs

‘It is a recognition of the scholarly environment and infrastructure we have built to enable and foster outstanding scientific research,’ says David Geffen School of Medicine Dean Kelsey Martin

Laurie Adami participated in the trial for the immunotherapy treatment, which received FDA approval March 5